A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.
Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New research from Sweden links higher levels of per- and polyfluoroalkyl ...
Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...
For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...
A collaborative team of researchers and students from Wayne State University's Eugene Applebaum College of Pharmacy and ...
Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing ...
Channel 4 has a new thriller on the way. Careless, starring Bridgerton's Katie Leung and House of the Dragon star Solly ...
By Ludwig Burger FRANKFURT, Jan 29 (Reuters) - Roche's adjusted operating income rose by a lower-than-expected 5% in 2025 as gains in drugs such as Ocrevus against multiple sclerosis and Hemlibra ...
Group results In 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 61.5 billion due to strong demand for pharmaceutical products and diagnostic solutions. The appreciation of the Swiss franc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results